The treatment of breast cancer cell lines, MCF-7 and MDA-MB-231, with andrographolide, demonstrates an inhibition of Bcl-2 and an increase in the expression and protein levels of Bax, further demonstrating the apoptotic effect of andrographolide on these breast cancer cell lines (142). This evidence concerns the gene BCL2 and breast carcinoma.